Clinical Trial Update: A Study To Investigate Safety, Blood Levels And Effects Of Giving GW642444, By Mouth, By Inhalation & By Injection [Phase 1]

View source ↗

Summary

A Phase 1 trial evaluating safety, blood levels, and effects of GW642444 administered orally, by inhalation, and by injection in chronic obstructive pulmonary d…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• GW642444 (GW642444)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Pulmonary Disease, Chronic Obstructive | Phase 1 | Status: COMPLETED